BIOMAT Database Logo BIOMAT Database Logo

Cerebrospinal fluid homovanillic acid is reduced in untreated Huntington's disease. 1995

P J García Ruiz, and M A Mena, and V Sanchez Bernardos, and W Díaz Neira, and S Gimenez Roldan, and J Benitez, and J García de Yebenes
Department of Neurology, Fundación Jimenez Díaz, Madrid, Spain.

We measured homovanillic acid (HVA), 5-hydroxy indole acetic acid (5-HIAA), and tryptophan (TP) in cerebrospinal fluid (CSF) of 20 neuroleptic-free patients with Huntington's disease (HD), and compared mean values with those from four control groups including 15 normal individuals, 38 patients with dystonia, 23 untreated patients with Parkinson's disease, and 61 patients with other neurological diseases (ONDs). The mean levels of HVA in the CSF of patients with HD were reduced compared with those from normal controls (p < 0.001), dystonic patients (p < 0.005), individuals with ONDs (p < 0.0001), and even from untreated parkinsonian patients (p < 0.05). 5-HIAA and TP levels in the CSF of patients with HD were not significantly different from those in the CSF of control patients. Our data suggest a reduced dopamine neurotransmission in HD and may account for the bradykinesia observed in our patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006719 Homovanillic Acid A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid. 3-Methoxy-4-Hydroxyphenylacetic Acid,4-Hydroxy-3-Methoxyphenylacetic Acid,3 Methoxy 4 Hydroxyphenylacetic Acid,4 Hydroxy 3 Methoxyphenylacetic Acid,Acid, 3-Methoxy-4-Hydroxyphenylacetic,Acid, 4-Hydroxy-3-Methoxyphenylacetic,Acid, Homovanillic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006816 Huntington Disease A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4) Huntington Chorea,Juvenile Huntington Disease,Akinetic-Rigid Variant of Huntington Disease,Chorea, Chronic Progressive Hereditary (Huntington),Chronic Progressive Hereditary Chorea (Huntington),Huntington Chronic Progressive Hereditary Chorea,Huntington Disease, Akinetic-Rigid Variant,Huntington Disease, Juvenile,Huntington Disease, Juvenile-Onset,Huntington Disease, Late Onset,Huntington's Chorea,Huntington's Disease,Juvenile-Onset Huntington Disease,Late-Onset Huntington Disease,Progressive Chorea, Chronic Hereditary (Huntington),Progressive Chorea, Hereditary, Chronic (Huntington),Akinetic Rigid Variant of Huntington Disease,Chorea, Huntington,Chorea, Huntington's,Huntington Disease, Akinetic Rigid Variant,Huntington Disease, Juvenile Onset,Huntington Disease, Late-Onset,Juvenile Onset Huntington Disease,Late Onset Huntington Disease
D006897 Hydroxyindoleacetic Acid 5-HIAA,5-Hydroxy-3-Indoleacetic Acid,5-Hydroxyindolamine Acetic Acid,5 Hydroxy 3 Indoleacetic Acid,5 Hydroxyindolamine Acetic Acid,Acetic Acid, 5-Hydroxyindolamine,Acid, 5-Hydroxy-3-Indoleacetic,Acid, 5-Hydroxyindolamine Acetic,Acid, Hydroxyindoleacetic
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014364 Tryptophan An essential amino acid that is necessary for normal growth in infants and for NITROGEN balance in adults. It is a precursor of INDOLE ALKALOIDS in plants. It is a precursor of SEROTONIN (hence its use as an antidepressant and sleep aid). It can be a precursor to NIACIN, albeit inefficiently, in mammals. Ardeydorm,Ardeytropin,L-Tryptophan,L-Tryptophan-ratiopharm,Levotryptophan,Lyphan,Naturruhe,Optimax,PMS-Tryptophan,Trofan,Tryptacin,Tryptan,Tryptophan Metabolism Alterations,ratio-Tryptophan,L Tryptophan,L Tryptophan ratiopharm,PMS Tryptophan,ratio Tryptophan

Related Publications

P J García Ruiz, and M A Mena, and V Sanchez Bernardos, and W Díaz Neira, and S Gimenez Roldan, and J Benitez, and J García de Yebenes
Cerebrospinal fluid homovanillic acid and parkinsonism in Huntington's disease.
August 1988, Annals of neurology,
P J García Ruiz, and M A Mena, and V Sanchez Bernardos, and W Díaz Neira, and S Gimenez Roldan, and J Benitez, and J García de Yebenes
Cerebrospinal fluid homovanillic acid in Huntington's chorea.
July 1971, Journal of the neurological sciences,
P J García Ruiz, and M A Mena, and V Sanchez Bernardos, and W Díaz Neira, and S Gimenez Roldan, and J Benitez, and J García de Yebenes
Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy.
January 1975, Neurology,
P J García Ruiz, and M A Mena, and V Sanchez Bernardos, and W Díaz Neira, and S Gimenez Roldan, and J Benitez, and J García de Yebenes
Cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid in huntington's chorea.
January 1974, Acta psychiatrica Scandinavica. Supplementum,
P J García Ruiz, and M A Mena, and V Sanchez Bernardos, and W Díaz Neira, and S Gimenez Roldan, and J Benitez, and J García de Yebenes
Cerebrospinal fluid homovanillic acid levels are not reduced in early corticobasal degeneration.
April 1998, Neuroscience letters,
P J García Ruiz, and M A Mena, and V Sanchez Bernardos, and W Díaz Neira, and S Gimenez Roldan, and J Benitez, and J García de Yebenes
Homovanillic acid in cerebrospinal fluid of alcoholics.
June 1973, The New England journal of medicine,
P J García Ruiz, and M A Mena, and V Sanchez Bernardos, and W Díaz Neira, and S Gimenez Roldan, and J Benitez, and J García de Yebenes
Cerebrospinal fluid homovanillic acid in cerebral infarction.
January 1978, Journal of neural transmission. Supplementum,
P J García Ruiz, and M A Mena, and V Sanchez Bernardos, and W Díaz Neira, and S Gimenez Roldan, and J Benitez, and J García de Yebenes
Reduced brain delivery of homovanillic acid to cerebrospinal fluid during human aging.
November 2004, Archives of neurology,
P J García Ruiz, and M A Mena, and V Sanchez Bernardos, and W Díaz Neira, and S Gimenez Roldan, and J Benitez, and J García de Yebenes
Evidence for reduced homovanillic acid (HVA) in the cerebrospinal fluid of patients with depression.
August 2019, Journal of affective disorders,
P J García Ruiz, and M A Mena, and V Sanchez Bernardos, and W Díaz Neira, and S Gimenez Roldan, and J Benitez, and J García de Yebenes
Cerebrospinal fluid homovanillic acid and iso-homovanillic acid: a gas-liquid chromatographic method.
March 1974, Journal of neurochemistry,
Copied contents to your clipboard!